PreventiOn of DYSbioSis Complications With Autologous FMT in AML Patients (ODYSSEE)
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP311250
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study was to demonstrate the safety of autologous fecal microbiota transfer (AFMT) in 25 AML patients treated with intensive chemotherapy and antibiotics, and to show its efficacy to restore their gut microbiota (ClinicalTrials.gov number: NCT02928523).
创建时间：
2021-03-19
